Skip Navigation

European Heart Journal 1990 11(Supplement B):27-34; doi:10.1093/eurheartj/11.suppl_B.27
Copyright © 1990 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Schrör, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schrör, K.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 1990 The European Society of Cardiology

Thromboxane A2 and platelets as mediators of coronary arterial vasoconstriction in myocardial ischaemia

K. Schrör

Institut für Pharmakologie, Heinrich-Heine-Universität Düsseldorf F.R.G.

Address for correspondence: Karsten Schrör, Institut für Pharmakologie, Heinrich-Heine-Universität Düldorf, Moorenstrasse 5, D-4000 Düsseldorf 1, F.R.G.

Thromboxane A2 (TXA2) a potent stimulus for platelet aggregation, secretion and vasoactive mediator release from platelets, endothelium and other cells in the vicinity.

Key Words: Thromboxane • thromboxane synthase inhibitors • myocardial ischaemia • thromboxane receptor antagonists • coronary circulation • platelet function


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.